People's United Financial’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $286K | Buy |
5,158
+370
| +8% | +$19K | 0.01% | 546 |
|
|
2021
Q4 | $268K | Sell |
4,788
-99,906
| -95% | -$5.41M | 0.01% | 605 |
|
|
2021
Q3 | $5.03M | Buy |
104,694
+6
| +0% | +$290 | 0.11% | 159 |
|
|
2021
Q2 | $4.38M | Buy |
104,688
+4
| +0% | +$155 | 0.1% | 169 |
|
|
2021
Q1 | $3.53M | Buy |
104,684
+174
| +0.2% | +$6.2K | 0.08% | 179 |
|
|
2020
Q4 | $3.65M | Sell |
104,510
-566
| -0.5% | -$19.6K | 0.09% | 162 |
|
|
2020
Q3 | $3.65M | Sell |
105,076
-52
| -0% | -$1.73K | 0.1% | 151 |
|
|
2020
Q2 | $3.44M | Buy |
105,128
+1,052
| +1% | +$33.6K | 0.1% | 149 |
|
|
2020
Q1 | $3.13M | Sell |
104,076
-354
| -0.3% | -$10.5K | 0.11% | 150 |
|
|
2019
Q4 | $3.02M | Buy |
+104,430
| New | +$2.89M | 0.08% | 186 |
|
|
2018
Q4 | – | Sell |
-10,570
| Closed | -$249K | – | 754 |
|
|
2018
Q3 | $249K | Sell |
10,570
-36,122
| -77% | -$882K | 0.01% | 656 |
|
|
2018
Q2 | $1.08M | Buy |
46,692
+3,732
| +9% | +$88.7K | 0.03% | 417 |
|
|
2018
Q1 | $1.06M | Sell |
42,960
-50
| -0.1% | -$1.31K | 0.03% | 351 |
|
|
2017
Q4 | $1.15M | Sell |
43,010
-476
| -1% | -$12.1K | 0.04% | 345 |
|
|
2017
Q3 | $1.05M | Buy |
43,486
+4,498
| +12% | +$102K | 0.04% | 344 |
|
|
2017
Q2 | $837K | Sell |
38,988
-3,140
| -7% | -$63.4K | 0.03% | 393 |
|
|
2017
Q1 | $722K | Buy |
42,128
+41,778
| +11,937% | +$727K | 0.03% | 406 |
|
|
2016
Q4 | $6K | Hold |
350
| – | – | ﹤0.01% | 915 |
|
|
2016
Q3 | $7K | Sell |
350
-22,840
| -98% | -$566K | ﹤0.01% | 767 |
|
|
2016
Q2 | $623K | Buy |
23,190
+2,600
| +13% | +$71.3K | 0.03% | 293 |
|
|
2016
Q1 | $557K | Sell |
20,590
-4,750
| -19% | -$127K | 0.03% | 312 |
|
|
2015
Q4 | $735K | Buy |
25,340
+1,600
| +7% | +$44.3K | 0.04% | 287 |
|
|
2015
Q3 | $643K | Sell |
23,740
-700
| -3% | -$19.8K | 0.04% | 302 |
|
|
2015
Q2 | $670K | Buy |
24,440
+400
| +2% | +$11.2K | 0.04% | 314 |
|
|
2015
Q1 | $641K | Sell |
24,040
-5,800
| -19% | -$134K | 0.03% | 324 |
|
|
2014
Q4 | $631K | Sell |
29,840
-160
| -0.5% | -$3.57K | 0.03% | 323 |
|
|
2014
Q3 | $714K | Sell |
30,000
-340
| -1% | -$7.82K | 0.04% | 298 |
|
|
2014
Q2 | $701K | Buy |
30,340
+29,990
| +8,569% | +$662K | 0.04% | 305 |
|
|
2014
Q1 | $8K | Hold |
350
| – | – | ﹤0.01% | 693 |
|
|
2013
Q4 | $6K | Hold |
350
| – | – | ﹤0.01% | 711 |
|
|
2013
Q3 | $6K | Hold |
350
| – | – | ﹤0.01% | 711 |
|
|
2013
Q2 | $5K | Buy |
+350
| New | +$5.83K | ﹤0.01% | 680 |
|
Other funds holding NVO
People's United Financial's NVO Position: Q1 2022 in Review
People's United Financial increased its Novo Nordisk (NVO) stake by 7.7% in Q1 2022, buying an estimated $19K and bringing the position to 5,158 shares worth $286K. The position accounts for 0.01% of the portfolio, ranked #546.
People's United Financial first reported a position in NVO in Q2 2013 and has held it in 32 quarters since. The position peaked at $5.03M in Q3 2021. 903 funds tracked by Wall St. Rank hold NVO as of Q1 2022.
- People's United Financial held 5,158 shares of Novo Nordisk worth $286K as of Q1 2022.
- People's United Financial bought 370 Novo Nordisk shares in Q1 2022, an estimated $19K.
- Novo Nordisk made up 0.01% of People's United Financial's portfolio in Q1 2022, its #546 holding.
- People's United Financial first reported a position in Novo Nordisk in Q2 2013 and has held it in 32 quarters since.
- People's United Financial's Novo Nordisk position peaked at $5.03M in Q3 2021.
- 903 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2022.
Based on People's United Financial's 13F filing for Q1 2022, filed 10 May 2022.